Introduction: Unlike Escherichia coli , Campylobacter jejuni is unable to import a range of sugars, including arabinose, which makes common expression vectors, such as pBAD33, non-functional in these bacteria.
Aim: The aim of this study was to investigate whether the E. coli transporters AraE and modified LacY (LacYA177C) would enable C. jejuni to uptake arabinose.
Methodology and results: The respective genes of E. coli were constitutively expressed in C. jejuni strain 11168H after integration into the chromosome via homologous recombination. Vectors carrying these genes also contained a reporter gene, gfp, under the control of the arabinose-inducible promoter, pBAD. These constructs were verified in E. coli by demonstrating the induction of gfp in the presence of arabinose.
Integration of the genes into one of the rRNA gene clusters was verified by PCR and genome sequencing. The latter also confirmed that the inserted gene clusters contained no mutations. Expression of the gfp gene in the presence of arabinose inducer was monitored using fluorescence microscopy of colonies and fluorimetry using both whole cells and lysates.
Conclusion: The results demonstrated the inability of C. jejuni to use arabinose transporters, which are fully functional in E. coli , suggesting a remarkable difference in the physiology of these bacteria.
Genome-Wide Analysis of Peptidoglycan Recognition Protein Genes in Fig Wasps (Hymenoptera, Chalcidoidea)
- The innate immunity is the most important defense against pathogen of insects, and the peptidoglycan recognition proteins (PGRPs) play an important role in the processes of immune recognition and initiation of Toll, IMD and other signal pathways. In fig wasps, pollinators and non-pollinators present different evolutionary histories and lifestyles, even though both are closely associated with fig syconia, which may indicate their different patterns in the evolution of PGRPs.
- By manual annotation, we got all the PGRP genes of 12 fig wasp species, containing seven pollinators and five non-pollinators, and investigated their putative different evolutionary patterns. We found that the number of PGRP genes in pollinators was significantly lower than in non-pollinators, and the number of catalytic PGRP presented a declining trend in pollinators.
- More importantly, PGRP-SA is associated with initiating the Toll pathway, as well as gram-negative bacteria-binding proteins (GNBPs), which were completely lost in pollinators, which led us to speculate that the initiation of Toll pathway was simpler in pollinators than in non-pollinators.
- We concluded that fig pollinators owned a more streamlined innate immune recognition system than non-pollinators. Our results provide molecular evidence for the adaptive evolution of innate immunity in insects of host specificity.
Comparative genomics of Alexander Fleming’s original Penicillium isolate (IMI 15378) reveals sequence divergence of penicillin synthesis genes
Antibiotics were derived originally from wild organisms and therefore understanding how these compounds evolve among different lineages might help with the design of new antimicrobial drugs. We report the draft genome sequence of Alexander Fleming’s original fungal isolate behind the discovery of penicillin, now classified as Penicillium rubens Biourge (1923) (IMI 15378). We compare the structure of the genome and genes involved in penicillin synthesis with those in two ‘high producing’ industrial strains of P. rubens and the closely related species P. nalgiovense.
The main effector genes for producing penicillin G (pcbAB, pcbC and penDE) show amino acid divergence between the Fleming strain and both industrial strains, whereas a suite of regulatory genes are conserved. Homologs of penicillin N effector genes cefD1 and cefD2 were also found and the latter displayed amino acid divergence between the Fleming strain and industrial strains.
The draft assemblies contain several partial duplications of penicillin-pathway genes in all three P. rubens strains, to differing degrees, which we hypothesise might be involved in regulation of the pathway. The two industrial strains are identical in sequence across all effector and regulatory genes but differ in duplication of the pcbAB-pcbC-penDE complex and partial duplication of fragments of regulatory genes. We conclude that evolution in the wild encompassed both sequence changes of the effector genes and gene duplication, whereas human-mediated changes through mutagenesis and artificial selection led to duplication of the penicillin pathway genes.

stjosephs-hospital
Transposon Insertion in the purL Gene Induces Biofilm Depletion in Escherichia coli ATCC 25922
Current Escherichia coli antibiofilm treatments comprise a combination of antibiotics commonly used against planktonic cells, leading to treatment failure. A better understanding of the genes involved in biofilm formation could facilitate the development of efficient and specific new antibiofilm treatments.
A total of 2578 E. coli mutants were generated by transposon insertion, of which 536 were analysed in this study. After sequencing, Tn263 mutant, classified as low biofilm-former (LF) compared to the wild-type (wt) strain (ATCC 25922), showed an interruption in the purL gene, involved in the de novo purine biosynthesis pathway.
To elucidate the role of purL in biofilm formation, a knockout was generated showing reduced production of curli fibres, leading to an impaired biofilm formation. These conditions were restored by complementation of the strain or addition of exogenous inosine. Proteomic and transcriptional analyses were performed to characterise the differences caused by purL alterations.
Thirteen proteins were altered compared to wt. The corresponding genes were analysed by qRT-PCR not only in the Tn263 and wt, but also in clinical strains with different biofilm activity. Overall, this study suggests that purL is essential for biofilm formation in E. coli and can be considered as a potential antibiofilm target.
Characterizing patient-oncologist communication in genomic tumor testing: The 21-gene recurrence score as an exemplar
Objective: Women with early-stage, ER + breast cancer are recommend to receive genomic profiling tests, such as the 21-gene Recurrence Score (RS) test, to guide treatment decisions. We examined test- and treatment-related information discussed and the associations between RS categories and aspects of communication during patient-oncologist clinical encounters.
Methods: As part of a larger trial, clinical encounters (N = 46) were audiorecorded and coded for 1) RS- and treatment-related information, 2) shared decision making, 3) patient active participation, and 4) oncologist patient-centered communication. We examined differences by RS category using mixed models, adjusting for nesting within oncologist.
Results: Patients with a high RS were more likely to receive a chemotherapy recommendation (p < .01), hear about the risks/side effects of chemotherapy (p < .01), and offer their preferences (p = .02) than those with intermediate or low RS. Elements of shared decision making increased with RS. Oncologist patient-centered communication (M = 4.09/5, SD = .25) and patient active participation (M = 3.5/4, SD = 1.0) were high across RS.
Conclusion: Findings suggest that disease severity, rather than clinical uncertainty, impact treatment recommendations and shared decision making.
Practice implications: Oncologists adjust test- and treatment-related information and shared decision making by disease severity. This information provides a framework to inform decision making in complex cancer and genomics settings.
ACTN3 Antibody |
1-CSB-PA124802 |
Cusabio |
|
|
|
Description: A polyclonal antibody against ACTN3. Recognizes ACTN3 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;ELISA:1:2000-1:5000, WB:1:500-1:2000 |
ACTN3 Antibody |
1-CSB-PA288460 |
Cusabio |
|
|
|
Description: A polyclonal antibody against ACTN3. Recognizes ACTN3 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;ELISA:1:2000-1:5000, WB:1:500-1:2000 |
ACTN3 Antibody |
1-CSB-PA000816 |
Cusabio |
|
|
|
Description: A polyclonal antibody against ACTN3. Recognizes ACTN3 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IF, ELISA;WB:1/500-1/2000.IF:1/200-1/1000.ELISA:1/20000 |
ACTN3 Antibody |
1-CSB-PA001243LA01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against ACTN3. Recognizes ACTN3 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IF; Recommended dilution: IF:1:50-1:200 |
ACTN3 Antibody |
R32494 |
NSJ Bioreagents |
100 ug |
EUR 356.15 |
Description: Alpha-actinin-3, also known as alpha-actinin skeletal muscle isoform 3 or F-actin cross-linking protein, is a protein that in humans is encoded by the ACTN3 gene. This gene encodes a member of the alpha-actin binding protein gene family. The encoded protein is primarily expressed in skeletal muscle and functions as a structural component of sarcomeric Z line. This protein is involved in crosslinking actin containing thin filaments. An allelic polymorphism in this gene results in both coding and non-coding variants; the reference genome represents the coding allele. The non-functional allele of this gene is associated with elite athlete status. |
ACTN2 / ACTN3 Antibody |
abx332374-100ul |
Abbexa |
100 ul |
EUR 510 |
|
ACTN2 / ACTN3 Antibody |
20-abx329446 |
Abbexa |
|
|
|
ACTN2/ACTN3 Antibody |
CSB-PA960396- |
Cusabio |
each |
EUR 402 |
|
Description: A polyclonal antibody against ACTN2/ACTN3. Recognizes ACTN2/ACTN3 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500 |
ACTN2/ACTN3 Antibody |
CSB-PA960396-100ul |
Cusabio |
100ul |
EUR 379.2 |
|
Description: A polyclonal antibody against ACTN2/ACTN3. Recognizes ACTN2/ACTN3 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500 |
ACTN2/ACTN3 Antibody |
1-CSB-PA000815 |
Cusabio |
|
|
|
Description: A polyclonal antibody against ACTN2/ACTN3. Recognizes ACTN2/ACTN3 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/20000 |
Polyclonal ACTN3 Antibody |
APR14796G |
Leading Biology |
0.1ml |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human ACTN3 . This antibody is tested and proven to work in the following applications: |
ACTN1 / ACTN2 / ACTN3 / ACTN4 Antibody |
abx332562-100ul |
Abbexa |
100 ul |
EUR 510 |
|
ACTN1 / ACTN2 / ACTN3 / ACTN4 Antibody |
20-abx328684 |
Abbexa |
|
|
|
ACTN1/ACTN2/ACTN3/ACTN4 Antibody |
CSB-PA096347- |
Cusabio |
each |
EUR 402 |
|
Description: A polyclonal antibody against ACTN1/ACTN2/ACTN3/ACTN4. Recognizes ACTN1/ACTN2/ACTN3/ACTN4 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000 |
ACTN1/ACTN2/ACTN3/ACTN4 Antibody |
CSB-PA096347-100ul |
Cusabio |
100ul |
EUR 379.2 |
|
Description: A polyclonal antibody against ACTN1/ACTN2/ACTN3/ACTN4. Recognizes ACTN1/ACTN2/ACTN3/ACTN4 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000 |
ACTN1/ACTN2/ACTN3/ACTN4 Antibody |
1-CSB-PA000814 |
Cusabio |
|
|
|
Description: A polyclonal antibody against ACTN1/ACTN2/ACTN3/ACTN4. Recognizes ACTN1/ACTN2/ACTN3/ACTN4 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/20000 |
ACTN3 Conjugated Antibody |
C34157 |
SAB |
100ul |
EUR 476.4 |
ACTN3 Antibody, HRP conjugated |
1-CSB-PA001243LB01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against ACTN3. Recognizes ACTN3 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
ACTN3 Antibody, FITC conjugated |
1-CSB-PA001243LC01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against ACTN3. Recognizes ACTN3 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
Polyclonal ACTN3 Antibody (Center) |
APR14798G |
Leading Biology |
0.1ml |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human ACTN3 (Center). This antibody is tested and proven to work in the following applications: |
ACTN3 Antibody, Biotin conjugated |
1-CSB-PA001243LD01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against ACTN3. Recognizes ACTN3 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
Actinin Alpha 3 (ACTN3) Antibody |
abx230122-100ug |
Abbexa |
100 ug |
EUR 610.8 |
|
Alpha Actinin 3 (ACTN3) Antibody |
20-abx213418 |
Abbexa |
|
|
|
Alpha Actinin 3 (ACTN3) Antibody |
20-abx213419 |
Abbexa |
|
|
|
Actinin Alpha 3 (ACTN3) Antibody |
abx026732-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
Actinin Alpha 3 (ACTN3) Antibody |
abx026732-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
Actinin Alpha 3 (ACTN3) Antibody |
20-abx013892 |
Abbexa |
-
EUR 376.80
-
EUR 117.60
-
EUR 477.60
-
EUR 594.00
|
-
100 ug
-
10 ug
-
200 ug
-
300 µg
|
|
Actinin Alpha 3 (ACTN3) Antibody |
abx038105-100ug |
Abbexa |
100 ug |
EUR 469.2 |
|
Actinin Alpha 3 (ACTN3) Antibody |
20-abx130639 |
Abbexa |
-
EUR 493.20
-
EUR 159.60
-
EUR 1378.80
-
EUR 678.00
-
EUR 376.80
|
-
100 ug
-
10 ug
-
1 mg
-
200 ug
-
50 ug
|
|
Alpha Actinin 3 (ACTN3) Antibody |
20-abx328117 |
Abbexa |
|
|
|
Actinin Alpha 3 (ACTN3) Antibody |
20-abx009624 |
Abbexa |
-
EUR 360.00
-
EUR 526.80
-
EUR 226.80
|
|
|
ACTN3 Antibody / Alpha Actinin 3 |
RQ4625 |
NSJ Bioreagents |
100ug |
EUR 356.15 |
Description: Alpha-actinin-3, also known as alpha-actinin skeletal muscle isoform 3 or F-actin cross-linking protein, is a protein that in humans is encoded by the ACTN3 gene. This gene encodes a member of the alpha-actin binding protein gene family. The encoded protein is primarily expressed in skeletal muscle and functions as a structural component of sarcomeric Z line. This protein is involved in crosslinking actin containing thin filaments. An allelic polymorphism in this gene results in both coding and non-coding variants; the reference genome represents the coding allele. The non-functional allele of this gene is associated with elite athlete status. |
Polyclonal ACTN3 Antibody (aa1-50) |
APR14797G |
Leading Biology |
0.05ml |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human ACTN3 (aa1-50). This antibody is tested and proven to work in the following applications: |
Anti-Human ACTN3 DyLight® 488 conjugated Antibody |
A02693-Dyl488 |
BosterBio |
100ug/vial |
EUR 412.8 |
Anti-Human ACTN3 DyLight® 550 conjugated Antibody |
A02693-Dyl550 |
BosterBio |
100ug/vial |
EUR 412.8 |
Actinin Alpha 3 (ACTN3) Polyclonal Antibody (Human) |
4-PAB104Hu01 |
Cloud-Clone |
-
EUR 286.80
-
EUR 2869.20
-
EUR 717.60
-
EUR 358.80
-
EUR 253.20
|
-
100ul
-
10ml
-
1ml
-
200ul
-
20ul
|
|
Description: A Rabbit polyclonal antibody against Human Actinin Alpha 3 (ACTN3) |
Actinin Alpha 3 (ACTN3) Polyclonal Antibody (Human), PE |
4-PAB104Hu01-PE |
Cloud-Clone |
-
EUR 344.40
-
EUR 3012.00
-
EUR 860.40
-
EUR 430.80
-
EUR 230.40
|
-
100ul
-
10ml
-
1ml
-
200ul
-
20ul
|
|
Description: A Rabbit polyclonal antibody against Human Actinin Alpha 3 (ACTN3). This antibody is labeled with PE. |
Actinin Alpha 3 (ACTN3) Polyclonal Antibody (Human), APC |
4-PAB104Hu01-APC |
Cloud-Clone |
-
EUR 399.60
-
EUR 3735.60
-
EUR 1046.40
-
EUR 507.60
-
EUR 258.00
|
-
100ul
-
10ml
-
1ml
-
200ul
-
20ul
|
|
Description: A Rabbit polyclonal antibody against Human Actinin Alpha 3 (ACTN3). This antibody is labeled with APC. |
Actinin Alpha 3 (ACTN3) Polyclonal Antibody (Human), Cy3 |
4-PAB104Hu01-Cy3 |
Cloud-Clone |
-
EUR 483.60
-
EUR 4930.80
-
EUR 1345.20
-
EUR 627.60
-
EUR 294.00
|
-
100ul
-
10ml
-
1ml
-
200ul
-
20ul
|
|
Description: A Rabbit polyclonal antibody against Human Actinin Alpha 3 (ACTN3). This antibody is labeled with Cy3. |
Actinin Alpha 3 (ACTN3) Polyclonal Antibody (Human), HRP |
4-PAB104Hu01-HRP |
Cloud-Clone |
-
EUR 366.00
-
EUR 3256.80
-
EUR 926.40
-
EUR 459.60
-
EUR 243.60
|
-
100ul
-
10ml
-
1ml
-
200ul
-
20ul
|
|
Description: A Rabbit polyclonal antibody against Human Actinin Alpha 3 (ACTN3). This antibody is labeled with HRP. |
Actinin Alpha 3 (ACTN3) Polyclonal Antibody (Human), FITC |
4-PAB104Hu01-FITC |
Cloud-Clone |
-
EUR 344.40
-
EUR 3012.00
-
EUR 860.40
-
EUR 430.80
-
EUR 230.40
|
-
100ul
-
10ml
-
1ml
-
200ul
-
20ul
|
|
Description: A Rabbit polyclonal antibody against Human Actinin Alpha 3 (ACTN3). This antibody is labeled with FITC. |
Actinin Alpha 3 (ACTN3) Polyclonal Antibody (Human), Biotinylated |
4-PAB104Hu01-Biotin |
Cloud-Clone |
-
EUR 363.60
-
EUR 2809.20
-
EUR 836.40
-
EUR 442.80
-
EUR 259.20
|
-
100ul
-
10ml
-
1ml
-
200ul
-
20ul
|
|
Description: A Rabbit polyclonal antibody against Human Actinin Alpha 3 (ACTN3). This antibody is labeled with Biotin. |
Actinin Alpha 3 (ACTN3) Polyclonal Antibody (Human), APC-Cy7 |
4-PAB104Hu01-APC-Cy7 |
Cloud-Clone |
-
EUR 656.40
-
EUR 7327.20
-
EUR 1948.80
-
EUR 872.40
-
EUR 372.00
|
-
100ul
-
10ml
-
1ml
-
200ul
-
20ul
|
|
Description: A Rabbit polyclonal antibody against Human Actinin Alpha 3 (ACTN3). This antibody is labeled with APC-Cy7. |
ACTN3 siRNA |
20-abx906644 |
Abbexa |
|
|
|
ACTN3 siRNA |
20-abx906645 |
Abbexa |
|
|
|
anti- ACTN2 antibody |
FNab00121 |
FN Test |
100µg |
EUR 606.3 |
|
Description: Antibody raised against ACTN2 |
anti- ACTN4 antibody |
FNab00123 |
FN Test |
100µg |
EUR 606.3 |
|
Description: Antibody raised against ACTN4 |
ACTN3 Rabbit pAb |
A12797-100ul |
Abclonal |
100 ul |
EUR 369.6 |
ACTN3 Rabbit pAb |
A12797-200ul |
Abclonal |
200 ul |
EUR 550.8 |
ACTN3 Rabbit pAb |
A12797-20ul |
Abclonal |
20 ul |
EUR 219.6 |
ACTN3 Rabbit pAb |
A12797-50ul |
Abclonal |
50 ul |
EUR 267.6 |
ACTN3 Rabbit pAb |
A12864-100ul |
Abclonal |
100 ul |
EUR 369.6 |
ACTN3 Rabbit pAb |
A12864-200ul |
Abclonal |
200 ul |
EUR 550.8 |
ACTN3 Rabbit pAb |
A12864-20ul |
Abclonal |
20 ul |
EUR 219.6 |
ACTN3 Rabbit pAb |
A12864-50ul |
Abclonal |
50 ul |
EUR 267.6 |
ACTN3 Blocking Peptide |
20-abx062207 |
Abbexa |
|
|
|
ACTN3 Blocking Peptide |
DF8016-BP |
Affbiotech |
1mg |
EUR 234 |
Rat ACTN3 ELISA Kit |
ERA0390 |
Abclonal |
96Tests |
EUR 625.2 |
Goat ACTN3 ELISA Kit |
EGTA0390 |
Abclonal |
96Tests |
EUR 625.2 |
Mouse ACTN3 ELISA Kit |
EMA0390 |
Abclonal |
96Tests |
EUR 625.2 |
Human ACTN3 ELISA Kit |
EHA0390 |
Abclonal |
96Tests |
EUR 625.2 |
Rabbit ACTN3 ELISA Kit |
ERTA0390 |
Abclonal |
96Tests |
EUR 625.2 |
Bovine ACTN3 ELISA Kit |
EBA0390 |
Abclonal |
96Tests |
EUR 625.2 |
Canine ACTN3 ELISA Kit |
ECA0390 |
Abclonal |
96Tests |
EUR 625.2 |
Porcine ACTN3 ELISA Kit |
EPA0390 |
Abclonal |
96Tests |
EUR 625.2 |
Anserini ACTN3 ELISA Kit |
EAA0390 |
Abclonal |
96Tests |
EUR 625.2 |
Human ACTN3 shRNA Plasmid |
20-abx950055 |
Abbexa |
|
|
|
Mouse ACTN3 shRNA Plasmid |
20-abx969019 |
Abbexa |
|
|
|
Anti-ACTN3 Antibody |
PB10026 |
BosterBio |
100ug/vial |
EUR 400.8 |
Anti-ACTN3 antibody |
STJ114663 |
St John's Laboratory |
100 µl |
EUR 332.4 |
Description: This gene encodes a member of the alpha-actin binding protein gene family. The encoded protein is primarily expressed in skeletal muscle and functions as a structural component of sarcomeric Z line. This protein is involved in crosslinking actin containing thin filaments. An allelic polymorphism in this gene results in both coding and non-coding variants; the reference genome represents the coding allele. The non-functional allele of this gene is associated with elite athlete status. |
Anti-ACTN3 antibody |
STJ114730 |
St John's Laboratory |
100 µl |
EUR 332.4 |
Description: This gene encodes a member of the alpha-actin binding protein gene family. The encoded protein is primarily expressed in skeletal muscle and functions as a structural component of sarcomeric Z line. This protein is involved in crosslinking actin containing thin filaments. An allelic polymorphism in this gene results in both coding and non-coding variants; the reference genome represents the coding allele. The non-functional allele of this gene is associated with elite athlete status. |
Anti-Alpha Actinin 4/ACTN4 Antibody |
PB9974 |
BosterBio |
100ug/vial |
EUR 400.8 |
Actn3 ORF Vector (Rat) (pORF) |
ORF063016 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Guinea Pig ACTN3 ELISA Kit |
EGA0390 |
Abclonal |
96Tests |
EUR 625.2 |
ACTN3 ORF Vector (Human) (pORF) |
ORF012141 |
ABM |
1.0 ug DNA |
EUR 424.8 |
Actn3 ORF Vector (Mouse) (pORF) |
ORF038023 |
ABM |
1.0 ug DNA |
EUR 607.2 |
ACTN3 ELISA Kit (Human) (OKEH04449) |
OKEH04449 |
Aviva Systems Biology |
96 Wells |
EUR 794.4 |
Description: Description of target: This gene encodes a member of the alpha-actin binding protein gene family. The encoded protein is primarily expressed in skeletal muscle and functions as a structural component of sarcomeric Z line. This protein is involved in crosslinking actin containing thin filaments. An allelic polymorphism in this gene results in both coding and non-coding variants; the reference genome represents the coding allele. The non-functional allele of this gene is associated with elite athlete status.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 4.1 pg/mL |
ACTN3 ELISA Kit (Mouse) (OKEH05687) |
OKEH05687 |
Aviva Systems Biology |
96 Wells |
EUR 794.4 |
Description: Description of target: F-actin cross-linking protein which is thought to anchor actin to a variety of intracellular structures. This is a bundling protein.;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 41 pg/mL |
Recombinant Actinin Alpha 3 (ACTN3) |
4-RPB104Hu01 |
Cloud-Clone |
-
EUR 550.08
-
EUR 271.20
-
EUR 1732.80
-
EUR 657.60
-
EUR 1195.20
-
EUR 444.00
-
EUR 4152.00
|
-
100 ug
-
10ug
-
1 mg
-
200 ug
-
500 ug
-
50ug
-
5 mg
|
|
Description: Recombinant Human Actinin Alpha 3 expressed in: E.coli |
Actinin Alpha 3 (ACTN3) CLIA Kit |
20-abx492418 |
Abbexa |
-
EUR 10282.80
-
EUR 5472.00
-
EUR 1262.40
|
-
10 × 96 tests
-
5 × 96 tests
-
96 tests
|
|
Actinin Alpha 3 (ACTN3) ELISA Kit |
20-abx156912 |
Abbexa |
-
EUR 8684.40
-
EUR 4626.00
-
EUR 1074.00
|
-
10 × 96 tests
-
5 × 96 tests
-
96 tests
|
|
Human Actinin Alpha 3 (ACTN3) Protein |
20-abx167185 |
Abbexa |
-
EUR 777.60
-
EUR 326.40
-
EUR 2331.60
-
EUR 910.80
-
EUR 560.40
|
-
100 ug
-
10 ug
-
1 mg
-
200 ug
-
50 ug
|
|
Actn3 sgRNA CRISPR Lentivector set (Rat) |
K6966901 |
ABM |
3 x 1.0 ug |
EUR 406.8 |